Shiloh
Editor, Senior Moderator
Source: http://www.remedium.ru/news/russian/detail.php?ID=26355
08.06.2009 11:14
ITAR-TASS news agency identified as the exclusive distributor of information about the development of epidsituatsii
SRI influenza identified ITAR-TASS news agency as an exclusive partner for the dissemination of information about the development of epidsituatsii, innovative designs, the rest of the media may refer to work with the received data, - said the head of the WHO Center in St. Petersburg RAMS academician Oleg Kiselev.
Speaking through информагентство ITAR-TASS reported to representatives of the journalistic community, academician Kiselev called the media "to curtail the spread of unhealthy rumors, panic and agitation around issues related to influenza pandemic preparedness."
In Russia, "the three laboratory confirmed cases of influenza A/H1N1 /, no deaths, new zavoznyh" episodes of this infection has not been registered. This correspondent. Itar-Tass reported today at the National Influenza Center at the World Health Organization / WHO / in St. Petersburg.
Epidemiologists explained, referring to WHO data, that from the beginning of June, "the number of laboratory confirmed cases of influenza A/H1N1 / in the world increased by 1 thousand 863, two of which ended in deaths." In doing so, "the largest number of new infections registered in the United States / 1 thousand 78 / Australian / 204 /, Canada / 194 / and the UK / 110. During this period, the infection was confirmed in another 4 countries - Bulgaria, Egypt, Lebanon and Nicaragua. "
The head of the WHO Center in St. Petersburg academician of RAMS, Oleg Kiselyov, who visited the previous day in the United States, stressed that, "according to the American virology, influenza virus A / H1N1 /" porcine origin has fundamental differences with the "old relative - virus H1N1 in 1918, triggered the famous "Spanish", which died in the world to 50 million people. " The current of his "brother" less pathogens, with no significant genetic properties - Kiselev said.
Colleagues from the United States, said he had expressed the belief that "a new virus is less dangerous than previously thought." Nevertheless, he warned, "the new virus causes a relatively high mortality rate - from 0,4 to 0,6%, quickly migrates to the continents, differ highly infectious or contagious." "Currently, a vaccine against the flu is not present, although the candidates received in the vaccine strains," - said the head of the center.
He also said that the highly pathogenic virus influenza A/H1N1 / sensitive to a number of antiviral drugs, including domestic farmsredstva. In particular, the Influenza Research Institute in St. Petersburg in cooperation with the Institute of Organic Synthesis, Ural Branch of RAS and Moscow Institute of Molecular Biology, Engelhardt they completed the project on the testing of innovative antiviral drug Triazavirina. Kiselev stressed that "this is a reliable means of protection against" pig flu ".
SRI St. Petersburg, he added, also confirms the high efficiency of the combined preparation based on the alpha - and gamma / Ingaron / - interferons against virus A / H1N1 / ". Previously, a set of recommended against bird flu H5N1, - said the academician. Currently, he explained, Research Institute of Influenza, on the recommendation of the Ministry of Health and sotsrazvitiya Russia "started a project on the synthesis of analogues of imported expensive drug" Tamiflu ", so that a complete import substitution all available in the world treatment of severe influenza."
Academic Kiselev also reported that "the delegation of the Ministry of Health and sotsrazvitiya Russia and RAMS will leave for Mexico in July to address" the provision of assistance to the country antiepidemic. "At the place erupted and redemption is now the epicenter of infection epidemiologists try to clarify the picture in detail and to clarify the origin of the virus forecasts of the probable epidsitatsii in the world, said Kiselev.
National Center for Influenza, WHO is implementing year-round in St. Petersburg epidmonitoring in 49 major Russian cities and share information with WHO headquarters in Geneva.
Source text: www.ami-tass.
08.06.2009 11:14
ITAR-TASS news agency identified as the exclusive distributor of information about the development of epidsituatsii
SRI influenza identified ITAR-TASS news agency as an exclusive partner for the dissemination of information about the development of epidsituatsii, innovative designs, the rest of the media may refer to work with the received data, - said the head of the WHO Center in St. Petersburg RAMS academician Oleg Kiselev.
Speaking through информагентство ITAR-TASS reported to representatives of the journalistic community, academician Kiselev called the media "to curtail the spread of unhealthy rumors, panic and agitation around issues related to influenza pandemic preparedness."
In Russia, "the three laboratory confirmed cases of influenza A/H1N1 /, no deaths, new zavoznyh" episodes of this infection has not been registered. This correspondent. Itar-Tass reported today at the National Influenza Center at the World Health Organization / WHO / in St. Petersburg.
Epidemiologists explained, referring to WHO data, that from the beginning of June, "the number of laboratory confirmed cases of influenza A/H1N1 / in the world increased by 1 thousand 863, two of which ended in deaths." In doing so, "the largest number of new infections registered in the United States / 1 thousand 78 / Australian / 204 /, Canada / 194 / and the UK / 110. During this period, the infection was confirmed in another 4 countries - Bulgaria, Egypt, Lebanon and Nicaragua. "
The head of the WHO Center in St. Petersburg academician of RAMS, Oleg Kiselyov, who visited the previous day in the United States, stressed that, "according to the American virology, influenza virus A / H1N1 /" porcine origin has fundamental differences with the "old relative - virus H1N1 in 1918, triggered the famous "Spanish", which died in the world to 50 million people. " The current of his "brother" less pathogens, with no significant genetic properties - Kiselev said.
Colleagues from the United States, said he had expressed the belief that "a new virus is less dangerous than previously thought." Nevertheless, he warned, "the new virus causes a relatively high mortality rate - from 0,4 to 0,6%, quickly migrates to the continents, differ highly infectious or contagious." "Currently, a vaccine against the flu is not present, although the candidates received in the vaccine strains," - said the head of the center.
He also said that the highly pathogenic virus influenza A/H1N1 / sensitive to a number of antiviral drugs, including domestic farmsredstva. In particular, the Influenza Research Institute in St. Petersburg in cooperation with the Institute of Organic Synthesis, Ural Branch of RAS and Moscow Institute of Molecular Biology, Engelhardt they completed the project on the testing of innovative antiviral drug Triazavirina. Kiselev stressed that "this is a reliable means of protection against" pig flu ".
SRI St. Petersburg, he added, also confirms the high efficiency of the combined preparation based on the alpha - and gamma / Ingaron / - interferons against virus A / H1N1 / ". Previously, a set of recommended against bird flu H5N1, - said the academician. Currently, he explained, Research Institute of Influenza, on the recommendation of the Ministry of Health and sotsrazvitiya Russia "started a project on the synthesis of analogues of imported expensive drug" Tamiflu ", so that a complete import substitution all available in the world treatment of severe influenza."
Academic Kiselev also reported that "the delegation of the Ministry of Health and sotsrazvitiya Russia and RAMS will leave for Mexico in July to address" the provision of assistance to the country antiepidemic. "At the place erupted and redemption is now the epicenter of infection epidemiologists try to clarify the picture in detail and to clarify the origin of the virus forecasts of the probable epidsitatsii in the world, said Kiselev.
National Center for Influenza, WHO is implementing year-round in St. Petersburg epidmonitoring in 49 major Russian cities and share information with WHO headquarters in Geneva.
Source text: www.ami-tass.